DTIL 424B5: Secondary offering
Filed with the SEC on · accession 0001628280-26-071249
DTIL filed a 424B5 (prospectus (offering)) with the SEC on Nov 6, 2026. The final terms of an offering of shares or bonds.
Summary of the filing
Precision BioSciences priced an underwritten public offering of 10,235,077 shares of common stock and pre-funded warrants to purchase 5,893,964 shares at $7.75 per share, raising approximately $117.5 million in net proceeds before expenses.
Key details
✦ Ask GOAX AI about this filing — what it means for DTIL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DTIL?
Click hereFrequently asked questions
What did DTIL file with the SEC on Nov 6, 2026?
DTIL filed a 424B5 (Secondary offering). Precision BioSciences priced an underwritten public offering of 10,235,077 shares of common stock and pre-funded warrants to purchase 5,893,964 shares at $7.75 per share, raising approximately $117.5 million in net proceeds before expenses.
What does a secondary offering mean for DTIL stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
Other DTIL SEC filings
Get alerts when DTIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days